These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 32586571)

  • 21. How to manage early-stage follicular lymphoma.
    Cencini E; Fabbri A; Mecacci B; Bocchia M
    Expert Rev Hematol; 2020 Oct; 13(10):1093-1105. PubMed ID: 32869685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical significance of tryptophan catabolism in follicular lymphoma.
    Masaki A; Ishida T; Maeda Y; Ito A; Suzuki S; Narita T; Kinoshita S; Yoshida T; Ri M; Kusumoto S; Komatsu H; Inagaki H; Ueda R; Choi I; Suehiro Y; Iida S
    Hematol Oncol; 2020 Dec; 38(5):742-753. PubMed ID: 32940915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early Stage Extranodal Follicular Lymphoma: Characteristics, Management, and Outcomes.
    Andraos T; Ayoub Z; Nastoupil L; Pinnix C; Milgrom S; Gunther J; Ng SP; Fowler N; Neelapu S; Samaniego F; Dabaja B
    Clin Lymphoma Myeloma Leuk; 2019 Jun; 19(6):381-389. PubMed ID: 30935940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Biological Basis of Histologic Transformation.
    Kumar EA; Okosun J; Fitzgibbon J
    Hematol Oncol Clin North Am; 2020 Aug; 34(4):771-784. PubMed ID: 32586580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transformation in Low-grade B-cell Neoplasms.
    Montgomery ND; Mathews SP
    Surg Pathol Clin; 2016 Mar; 9(1):79-92. PubMed ID: 26940269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Follicular lymphomas.
    Vitolo U; Ferreri AJ; Montoto S
    Crit Rev Oncol Hematol; 2008 Jun; 66(3):248-61. PubMed ID: 18359244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disappearance of CD21-positive follicular dendritic cells preceding the transformation of follicular lymphoma: immunohistological study of the transformation using CD21, p53, Ki-67, and P-glycoprotein.
    Shiozawa E; Yamochi-Onizuka T; Yamochi T; Yamamoto Y; Naitoh H; Kawakami K; Nakamaki T; Tomoyasu S; Kushima M; Ota H
    Pathol Res Pract; 2003; 199(5):293-302. PubMed ID: 12908519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transformed follicular lymphoma.
    Fischer T; Zing NPC; Chiattone CS; Federico M; Luminari S
    Ann Hematol; 2018 Jan; 97(1):17-29. PubMed ID: 29043381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term survival after histologic transformation of low-grade follicular lymphoma.
    Yuen AR; Kamel OW; Halpern J; Horning SJ
    J Clin Oncol; 1995 Jul; 13(7):1726-33. PubMed ID: 7602362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel Agents Beyond Immunomodulatory Agents and Phosphoinositide-3-Kinase for Follicular Lymphoma.
    Chin CK; Nastoupil LJ
    Hematol Oncol Clin North Am; 2020 Aug; 34(4):743-756. PubMed ID: 32586578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is watch and wait still acceptable for patients with low-grade follicular lymphoma?
    Armitage JO; Longo DL
    Blood; 2016 Jun; 127(23):2804-8. PubMed ID: 26994147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic factors in follicular lymphoma: new tools to personalize risk.
    Casulo C
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):269-276. PubMed ID: 27913491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Double-hit follicular lymphoma with MYC and BCL2 translocations: a study of 7 cases with a review of literature.
    Miao Y; Hu S; Lu X; Li S; Wang W; Medeiros LJ; Lin P
    Hum Pathol; 2016 Dec; 58():72-77. PubMed ID: 27544800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Open questions in watchful waiting for follicular lymphoma.
    Sorigue M; Sancho JM; Ribera JM
    Br J Haematol; 2017 Nov; 179(4):679-681. PubMed ID: 27390920
    [No Abstract]   [Full Text] [Related]  

  • 35. Pathology of follicular lymphoma.
    Takata K; Miyata-Takata T; Sato Y; Yoshino T
    J Clin Exp Hematop; 2014; 54(1):3-9. PubMed ID: 24942941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic factors in follicular lymphoma.
    Relander T; Johnson NA; Farinha P; Connors JM; Sehn LH; Gascoyne RD
    J Clin Oncol; 2010 Jun; 28(17):2902-13. PubMed ID: 20385990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor sclerosis but not cell proliferation or malignancy grade is a prognostic marker in advanced-stage follicular lymphoma: the German Low Grade Lymphoma Study Group.
    Klapper W; Hoster E; Rölver L; Schrader C; Janssen D; Tiemann M; Bernd HW; Determann O; Hansmann ML; Möller P; Feller A; Stein H; Wacker HH; Dreyling M; Unterhalt M; Hiddemann W; Ott G;
    J Clin Oncol; 2007 Aug; 25(22):3330-6. PubMed ID: 17664481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dissecting follicular lymphoma: high versus low risk.
    Smith SM
    Hematology Am Soc Hematol Educ Program; 2013; 2013():561-7. PubMed ID: 24319232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Follicular Lymphoma: Past, Present, and Future.
    Becnel MR; Nastoupil LJ
    Curr Treat Options Oncol; 2018 May; 19(7):32. PubMed ID: 29796824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Follicular lymphoma in early stages: high risk of relapse and usefulness of the Follicular Lymphoma International Prognostic Index to predict the outcome of patients.
    Plancarte F; López-Guillermo A; Arenillas L; Montoto S; Giné E; Muntañola A; Ferrer A; Villamor N; Bosch F; Colomo L; Balaguer O; Campo E; Montserrat E
    Eur J Haematol; 2006 Jan; 76(1):58-63. PubMed ID: 16343272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.